• contact BIO

    brought to you by
    Biotechnology Industry Organization
    1201 Maryland Ave., SW
    Washington, DC 20024
    202.962.9200
    www.bio.org

    terms of use
    privacy policy
  • Categories

  • Twitter Updates

VC looking for women-led biotechs

Is your life sciences company led by women?
Springboard Enterprises is looking for women-led science companies to present at AllThingsLifeSciences 2009 — a venture forum showcasing early and later stage biotech, medical device, health care IT, products & services and other life science companies.
According to Venture-Catalyst Springboard Enterprises, it is
“the go-to organization for information about and [...]

Google to get into the biotech biz

The economic news this week wasn’t all doom and gloom – Google announced Google Ventures, a new venture capital fund that will finance biotechnology start ups, among other things.

According to Google Blog:

At its core, Google Ventures is charged with finding and helping to develop exceptional start-ups. We’ll be focusing on early stage investments across [...]

Who Benefits from SBIR

In St. Louis, another small biotech firm is contemplating what steps to take if the SBIR bill is not renewed soon. Currently, Kereos Inc., a 15-employee company studying promising new methods of detecting and treating cancer is excluded from the SBIR program. This piece in Sunday’s St. Louis Post Dispatch illustrates the struggles that many [...]

Senate Small Business Committee Passes an SBIR bill

The Senate Small Business Committee has passed an SBIR reauthorization bill. We hope the House and Senate will work together to pass a final reauthorization bill before this program is set to expire on September 30, 2008.
From the Puget Sound Business Journal:

Under a compromise negotiated in the U.S. Senate, small companies that are majority-owned [...]

SBIR in the Wall Street Journal

With three weeks remaining before the August recess, time is running short for the Senate to continue to meet regarding the SBIR bill. (NOTE: the House passed a SBIR reauthorization bill in April). Yesterday the Wall Street Journal ran a piece outlining the debate on who should receive these SBIR grants: Should a small business [...]

Chat with John Risner, President of the Children’s Tumor Foundation

Hopes and Cures spokes to John Risner, President of The Children’s Tumor Foundation about the group’s work, in particular about funding for research.  CTF is a non-profit 501(c) (3) medical foundation, dedicated to improving the health and well being of individuals and families affected by the neurofibromatosis (NF).
 
ABOUT NF
Neurofibromatosis (NF) is the term for [...]

Biotechnology, a Massachusetts Force

Recently, there was an interesting study conducted by PricewaterhouseCoopers, the New England Healthcare Institute, the Massachusetts Life Sciences Center, Xconomy and the Massachusetts Technology Collaborative on the Massachusetts Life Sciences Super Cluster, showing the value of a strong science sector economically.   This Super Cluster includes Universities, teaching hospitals, biotechnology, medical device, and pharmaceutical companies.  Software, [...]

News Round Up (June 11)

SBIR Stories

Free Money Myths from the Government

Give Me Fish nets Phase 0 award

Blog Posts

Venture Capital Alternatives: SBIR

Just How Short-sighted is the VC Community?

NIH SBIR Comes to Atlanta

Startup Gets it Wrong: Part II

Fortune Small Business Volume 18; Issue 3
Funding research to develop cures for life-saving diseases is not a laughing matter, and we shouldn’t be making public policy based on cartoons. Small biotechnology companies, like the innovative and fast-thinking Jerry of the Tom & Jerry cartoon, deserve to succeed, but it’s the Small Business Administration that is [...]